GLOW Stock Overview
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Glow Lifetech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.13 |
| 52 Week Low | CA$0.02 |
| Beta | 2.56 |
| 1 Month Change | -16.67% |
| 3 Month Change | -16.67% |
| 1 Year Change | -68.75% |
| 3 Year Change | -93.42% |
| 5 Year Change | n/a |
| Change since IPO | -96.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| GLOW | CA Pharmaceuticals | CA Market | |
|---|---|---|---|
| 7D | -16.7% | 26.2% | -1.1% |
| 1Y | -68.8% | 84.7% | 4.9% |
Return vs Industry: GLOW underperformed the Canadian Pharmaceuticals industry which returned 45.6% over the past year.
Return vs Market: GLOW underperformed the Canadian Market which returned 5.1% over the past year.
Price Volatility
| GLOW volatility | |
|---|---|
| GLOW Average Weekly Movement | 39.8% |
| Pharmaceuticals Industry Average Movement | 15.1% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: GLOW's share price has been volatile over the past 3 months.
Volatility Over Time: GLOW's weekly volatility (40%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Rob Carducci | glowlifetech.com |
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products in North America. The company engages in the commercialization of plant-based MyCell technology delivery system, which transforms poorly absorbed natural compounds into enhanced water-compatible concentrates that unlock the full healing potential of the valuable compounds. The company has the exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K, and iron.
Glow Lifetech Corp. Fundamentals Summary
| GLOW fundamental statistics | |
|---|---|
| Market cap | CA$2.04m |
| Earnings (TTM) | -CA$1.99m |
| Revenue (TTM) | CA$19.49k |
104.5x
P/S Ratio-1.0x
P/E RatioIs GLOW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GLOW income statement (TTM) | |
|---|---|
| Revenue | CA$19.49k |
| Cost of Revenue | CA$23.45k |
| Gross Profit | -CA$3.96k |
| Other Expenses | CA$1.99m |
| Earnings | -CA$1.99m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.024 |
| Gross Margin | -20.30% |
| Net Profit Margin | -10,231.99% |
| Debt/Equity Ratio | 8,485.3% |
How did GLOW perform over the long term?
See historical performance and comparison